Connection

KEITH WEBSTER to Chromogranins

This is a "connection" page, showing publications KEITH WEBSTER has written about Chromogranins.
Connection Strength

0.905
  1. Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy. Cell Mol Life Sci. 2022 Jan 10; 79(1):63.
    View in: PubMed
    Score: 0.184
  2. Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization. FASEB J. 2022 01; 36(1):e22106.
    View in: PubMed
    Score: 0.183
  3. Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy. Int J Mol Sci. 2021 Dec 29; 23(1).
    View in: PubMed
    Score: 0.183
  4. Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies. Int J Mol Sci. 2021 May 01; 22(9).
    View in: PubMed
    Score: 0.175
  5. Secretogranin III: a diabetic retinopathy-selective angiogenic factor. Cell Mol Life Sci. 2018 02; 75(4):635-647.
    View in: PubMed
    Score: 0.136
  6. Neurovascular regulation in diabetic retinopathy and emerging therapies. Cell Mol Life Sci. 2021 Aug; 78(16):5977-5985.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.